MyFinsight
Home
Blog
About
Contact
Download
Download image
Tax and other
receivables
$1,454,756
Collaboration receivables
$1,213,226
Prepaid expenses and
other current assets
$650,429
Short-term investments
$13,866,546
Cash and cash
equivalents
$5,508,899
Other assets
$58,135
Operating lease
right-of-use assets
$318,036
Intangible assets and
in-process r&d, net
$6,687,100
Restricted cash
$4,520
Property and equipment,
net
$101,807
Total current assets
$22,693,856
Total assets
$29,863,454
Total liabilities and
stockholders equity
$29,863,454
Total stockholders
equity
$22,410,742
Total liabilities
$7,452,712
Accumulated other
comprehensive loss
-$243,708
Accumulated deficit
-$147,700,755
Additional paid-in capital
$170,083,195
Total non-current
liabilities
$4,872,352
Total current
liabilities
$2,580,360
Common stock, 0.01 par
value 150,000,000...
$272,006
Preferred stock, 0.01 par
value 10,000,000...
$4
Non-current operating lease
liabilities
$248,239
Deferred collaboration
revenue
$1,250,000
Deferred tax liability
$490,690
Contingent consideration
$2,883,423
Operating lease
liabilities
$155,926
Accrued expenses
$2,153,906
Accrued collaboration
credit
$29,057
Accounts payable
$241,471
Back
Back
Balance Sheet
source: myfinsight.com
KIORA PHARMACEUTICALS INC (KPHMW)
KIORA PHARMACEUTICALS INC (KPHMW)